Medical Care
Global Mumps Virus Vaccine Live Market Research Report 2026
- Feb 24, 26
- ID: 706573
- Pages: 90
- Figures: 95
- Views: 7
This report delivers a comprehensive overview of the global Mumps Virus Vaccine Live market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mumps Virus Vaccine Live. The Mumps Virus Vaccine Live market size, estimates, and forecasts are provided in terms of sales volume (KG) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Mumps Virus Vaccine Live market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mumps Virus Vaccine Live manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck
GSK
SINOVAC
AIM Vaccine
Shanghai Institute of Biological Products
Segment by Type
Single-dose Medication
Combination Medication
by Application
Children
Adults
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Mumps Virus Vaccine Live manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Mumps Virus Vaccine Live sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Mumps Virus Vaccine Live market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mumps Virus Vaccine Live manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck
GSK
SINOVAC
AIM Vaccine
Shanghai Institute of Biological Products
Segment by Type
Single-dose Medication
Combination Medication
by Application
Children
Adults
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Mumps Virus Vaccine Live manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Mumps Virus Vaccine Live sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Mumps Virus Vaccine Live Market Overview
1.1 Product Definition
1.2 Mumps Virus Vaccine Live by Type
1.2.1 Global Mumps Virus Vaccine Live Market Value by Type: 2025 vs 2032
1.2.2 Single-dose Medication
1.2.3 Combination Medication
1.3 Mumps Virus Vaccine Live by Application
1.3.1 Global Mumps Virus Vaccine Live Market Value by Application: 2025 vs 2032
1.3.2 Children
1.3.3 Adults
1.4 Global Mumps Virus Vaccine Live Market Size Estimates and Forecasts
1.4.1 Global Mumps Virus Vaccine Live Revenue 2021–2032
1.4.2 Global Mumps Virus Vaccine Live Sales 2021–2032
1.4.3 Global Mumps Virus Vaccine Live Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Mumps Virus Vaccine Live Market Competition by Manufacturers
2.1 Global Mumps Virus Vaccine Live Sales Market Share by Manufacturers (2021–2026)
2.2 Global Mumps Virus Vaccine Live Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Mumps Virus Vaccine Live Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Mumps Virus Vaccine Live, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Mumps Virus Vaccine Live, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Mumps Virus Vaccine Live, Product Types and Applications
2.7 Global Key Manufacturers of Mumps Virus Vaccine Live, Date of Entry into the Industry
2.8 Global Mumps Virus Vaccine Live Market Competitive Situation and Trends
2.8.1 Global Mumps Virus Vaccine Live Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Mumps Virus Vaccine Live Players Market Share by Revenue
2.8.3 Global Mumps Virus Vaccine Live Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mumps Virus Vaccine Live Market Scenario by Region
3.1 Global Mumps Virus Vaccine Live Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Mumps Virus Vaccine Live Sales by Region: 2021–2032
3.2.1 Global Mumps Virus Vaccine Live Sales by Region: 2021–2026
3.2.2 Global Mumps Virus Vaccine Live Sales by Region: 2027–2032
3.3 Global Mumps Virus Vaccine Live Revenue by Region: 2021–2032
3.3.1 Global Mumps Virus Vaccine Live Revenue by Region: 2021–2026
3.3.2 Global Mumps Virus Vaccine Live Revenue by Region: 2027–2032
3.4 North America Mumps Virus Vaccine Live Market Facts & Figures by Country
3.4.1 North America Mumps Virus Vaccine Live Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Mumps Virus Vaccine Live Sales by Country (2021–2032)
3.4.3 North America Mumps Virus Vaccine Live Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mumps Virus Vaccine Live Market Facts & Figures by Country
3.5.1 Europe Mumps Virus Vaccine Live Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Mumps Virus Vaccine Live Sales by Country (2021–2032)
3.5.3 Europe Mumps Virus Vaccine Live Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mumps Virus Vaccine Live Market Facts & Figures by Region
3.6.1 Asia Pacific Mumps Virus Vaccine Live Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Mumps Virus Vaccine Live Sales by Region (2021–2032)
3.6.3 Asia Pacific Mumps Virus Vaccine Live Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mumps Virus Vaccine Live Market Facts & Figures by Country
3.7.1 Latin America Mumps Virus Vaccine Live Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Mumps Virus Vaccine Live Sales by Country (2021–2032)
3.7.3 Latin America Mumps Virus Vaccine Live Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mumps Virus Vaccine Live Market Facts & Figures by Country
3.8.1 Middle East and Africa Mumps Virus Vaccine Live Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Mumps Virus Vaccine Live Sales by Country (2021–2032)
3.8.3 Middle East and Africa Mumps Virus Vaccine Live Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mumps Virus Vaccine Live Sales by Type (2021–2032)
4.1.1 Global Mumps Virus Vaccine Live Sales by Type (2021–2026)
4.1.2 Global Mumps Virus Vaccine Live Sales by Type (2027–2032)
4.1.3 Global Mumps Virus Vaccine Live Sales Market Share by Type (2021–2032)
4.2 Global Mumps Virus Vaccine Live Revenue by Type (2021–2032)
4.2.1 Global Mumps Virus Vaccine Live Revenue by Type (2021–2026)
4.2.2 Global Mumps Virus Vaccine Live Revenue by Type (2027–2032)
4.2.3 Global Mumps Virus Vaccine Live Revenue Market Share by Type (2021–2032)
4.3 Global Mumps Virus Vaccine Live Price by Type (2021–2032)
5 Segment by Application
5.1 Global Mumps Virus Vaccine Live Sales by Application (2021–2032)
5.1.1 Global Mumps Virus Vaccine Live Sales by Application (2021–2026)
5.1.2 Global Mumps Virus Vaccine Live Sales by Application (2027–2032)
5.1.3 Global Mumps Virus Vaccine Live Sales Market Share by Application (2021–2032)
5.2 Global Mumps Virus Vaccine Live Revenue by Application (2021–2032)
5.2.1 Global Mumps Virus Vaccine Live Revenue by Application (2021–2026)
5.2.2 Global Mumps Virus Vaccine Live Revenue by Application (2027–2032)
5.2.3 Global Mumps Virus Vaccine Live Revenue Market Share by Application (2021–2032)
5.3 Global Mumps Virus Vaccine Live Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Mumps Virus Vaccine Live Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK Mumps Virus Vaccine Live Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 SINOVAC
6.3.1 SINOVAC Company Information
6.3.2 SINOVAC Description and Business Overview
6.3.3 SINOVAC Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 SINOVAC Mumps Virus Vaccine Live Product Portfolio
6.3.5 SINOVAC Recent Developments/Updates
6.4 AIM Vaccine
6.4.1 AIM Vaccine Company Information
6.4.2 AIM Vaccine Description and Business Overview
6.4.3 AIM Vaccine Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 AIM Vaccine Mumps Virus Vaccine Live Product Portfolio
6.4.5 AIM Vaccine Recent Developments/Updates
6.5 Shanghai Institute of Biological Products
6.5.1 Shanghai Institute of Biological Products Company Information
6.5.2 Shanghai Institute of Biological Products Description and Business Overview
6.5.3 Shanghai Institute of Biological Products Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Shanghai Institute of Biological Products Mumps Virus Vaccine Live Product Portfolio
6.5.5 Shanghai Institute of Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mumps Virus Vaccine Live Industry Chain Analysis
7.2 Mumps Virus Vaccine Live Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mumps Virus Vaccine Live Production Mode & Process Analysis
7.4 Mumps Virus Vaccine Live Sales and Marketing
7.4.1 Mumps Virus Vaccine Live Sales Channels
7.4.2 Mumps Virus Vaccine Live Distributors
7.5 Mumps Virus Vaccine Live Customer Analysis
8 Mumps Virus Vaccine Live Market Dynamics
8.1 Mumps Virus Vaccine Live Industry Trends
8.2 Mumps Virus Vaccine Live Market Drivers
8.3 Mumps Virus Vaccine Live Market Challenges
8.4 Mumps Virus Vaccine Live Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Mumps Virus Vaccine Live by Type
1.2.1 Global Mumps Virus Vaccine Live Market Value by Type: 2025 vs 2032
1.2.2 Single-dose Medication
1.2.3 Combination Medication
1.3 Mumps Virus Vaccine Live by Application
1.3.1 Global Mumps Virus Vaccine Live Market Value by Application: 2025 vs 2032
1.3.2 Children
1.3.3 Adults
1.4 Global Mumps Virus Vaccine Live Market Size Estimates and Forecasts
1.4.1 Global Mumps Virus Vaccine Live Revenue 2021–2032
1.4.2 Global Mumps Virus Vaccine Live Sales 2021–2032
1.4.3 Global Mumps Virus Vaccine Live Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Mumps Virus Vaccine Live Market Competition by Manufacturers
2.1 Global Mumps Virus Vaccine Live Sales Market Share by Manufacturers (2021–2026)
2.2 Global Mumps Virus Vaccine Live Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Mumps Virus Vaccine Live Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Mumps Virus Vaccine Live, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Mumps Virus Vaccine Live, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Mumps Virus Vaccine Live, Product Types and Applications
2.7 Global Key Manufacturers of Mumps Virus Vaccine Live, Date of Entry into the Industry
2.8 Global Mumps Virus Vaccine Live Market Competitive Situation and Trends
2.8.1 Global Mumps Virus Vaccine Live Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Mumps Virus Vaccine Live Players Market Share by Revenue
2.8.3 Global Mumps Virus Vaccine Live Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mumps Virus Vaccine Live Market Scenario by Region
3.1 Global Mumps Virus Vaccine Live Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Mumps Virus Vaccine Live Sales by Region: 2021–2032
3.2.1 Global Mumps Virus Vaccine Live Sales by Region: 2021–2026
3.2.2 Global Mumps Virus Vaccine Live Sales by Region: 2027–2032
3.3 Global Mumps Virus Vaccine Live Revenue by Region: 2021–2032
3.3.1 Global Mumps Virus Vaccine Live Revenue by Region: 2021–2026
3.3.2 Global Mumps Virus Vaccine Live Revenue by Region: 2027–2032
3.4 North America Mumps Virus Vaccine Live Market Facts & Figures by Country
3.4.1 North America Mumps Virus Vaccine Live Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Mumps Virus Vaccine Live Sales by Country (2021–2032)
3.4.3 North America Mumps Virus Vaccine Live Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mumps Virus Vaccine Live Market Facts & Figures by Country
3.5.1 Europe Mumps Virus Vaccine Live Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Mumps Virus Vaccine Live Sales by Country (2021–2032)
3.5.3 Europe Mumps Virus Vaccine Live Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mumps Virus Vaccine Live Market Facts & Figures by Region
3.6.1 Asia Pacific Mumps Virus Vaccine Live Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Mumps Virus Vaccine Live Sales by Region (2021–2032)
3.6.3 Asia Pacific Mumps Virus Vaccine Live Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mumps Virus Vaccine Live Market Facts & Figures by Country
3.7.1 Latin America Mumps Virus Vaccine Live Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Mumps Virus Vaccine Live Sales by Country (2021–2032)
3.7.3 Latin America Mumps Virus Vaccine Live Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mumps Virus Vaccine Live Market Facts & Figures by Country
3.8.1 Middle East and Africa Mumps Virus Vaccine Live Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Mumps Virus Vaccine Live Sales by Country (2021–2032)
3.8.3 Middle East and Africa Mumps Virus Vaccine Live Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mumps Virus Vaccine Live Sales by Type (2021–2032)
4.1.1 Global Mumps Virus Vaccine Live Sales by Type (2021–2026)
4.1.2 Global Mumps Virus Vaccine Live Sales by Type (2027–2032)
4.1.3 Global Mumps Virus Vaccine Live Sales Market Share by Type (2021–2032)
4.2 Global Mumps Virus Vaccine Live Revenue by Type (2021–2032)
4.2.1 Global Mumps Virus Vaccine Live Revenue by Type (2021–2026)
4.2.2 Global Mumps Virus Vaccine Live Revenue by Type (2027–2032)
4.2.3 Global Mumps Virus Vaccine Live Revenue Market Share by Type (2021–2032)
4.3 Global Mumps Virus Vaccine Live Price by Type (2021–2032)
5 Segment by Application
5.1 Global Mumps Virus Vaccine Live Sales by Application (2021–2032)
5.1.1 Global Mumps Virus Vaccine Live Sales by Application (2021–2026)
5.1.2 Global Mumps Virus Vaccine Live Sales by Application (2027–2032)
5.1.3 Global Mumps Virus Vaccine Live Sales Market Share by Application (2021–2032)
5.2 Global Mumps Virus Vaccine Live Revenue by Application (2021–2032)
5.2.1 Global Mumps Virus Vaccine Live Revenue by Application (2021–2026)
5.2.2 Global Mumps Virus Vaccine Live Revenue by Application (2027–2032)
5.2.3 Global Mumps Virus Vaccine Live Revenue Market Share by Application (2021–2032)
5.3 Global Mumps Virus Vaccine Live Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Mumps Virus Vaccine Live Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK Mumps Virus Vaccine Live Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 SINOVAC
6.3.1 SINOVAC Company Information
6.3.2 SINOVAC Description and Business Overview
6.3.3 SINOVAC Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 SINOVAC Mumps Virus Vaccine Live Product Portfolio
6.3.5 SINOVAC Recent Developments/Updates
6.4 AIM Vaccine
6.4.1 AIM Vaccine Company Information
6.4.2 AIM Vaccine Description and Business Overview
6.4.3 AIM Vaccine Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 AIM Vaccine Mumps Virus Vaccine Live Product Portfolio
6.4.5 AIM Vaccine Recent Developments/Updates
6.5 Shanghai Institute of Biological Products
6.5.1 Shanghai Institute of Biological Products Company Information
6.5.2 Shanghai Institute of Biological Products Description and Business Overview
6.5.3 Shanghai Institute of Biological Products Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Shanghai Institute of Biological Products Mumps Virus Vaccine Live Product Portfolio
6.5.5 Shanghai Institute of Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mumps Virus Vaccine Live Industry Chain Analysis
7.2 Mumps Virus Vaccine Live Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mumps Virus Vaccine Live Production Mode & Process Analysis
7.4 Mumps Virus Vaccine Live Sales and Marketing
7.4.1 Mumps Virus Vaccine Live Sales Channels
7.4.2 Mumps Virus Vaccine Live Distributors
7.5 Mumps Virus Vaccine Live Customer Analysis
8 Mumps Virus Vaccine Live Market Dynamics
8.1 Mumps Virus Vaccine Live Industry Trends
8.2 Mumps Virus Vaccine Live Market Drivers
8.3 Mumps Virus Vaccine Live Market Challenges
8.4 Mumps Virus Vaccine Live Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Mumps Virus Vaccine Live Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Mumps Virus Vaccine Live Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Mumps Virus Vaccine Live Market Competitive Situation by Manufacturers in 2025
Table 4. Global Mumps Virus Vaccine Live Sales (KG) of Key Manufacturers (2021–2026)
Table 5. Global Mumps Virus Vaccine Live Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Mumps Virus Vaccine Live Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Mumps Virus Vaccine Live Average Price (US$/G) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Mumps Virus Vaccine Live, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Mumps Virus Vaccine Live, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Mumps Virus Vaccine Live, Product Types and Applications
Table 12. Global Key Manufacturers of Mumps Virus Vaccine Live, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mumps Virus Vaccine Live Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mumps Virus Vaccine Live Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mumps Virus Vaccine Live Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Mumps Virus Vaccine Live Sales by Region (KG), 2021–2026
Table 18. Global Mumps Virus Vaccine Live Sales Market Share by Region (2021–2026)
Table 19. Global Mumps Virus Vaccine Live Sales by Region (KG), 2027–2032
Table 20. Global Mumps Virus Vaccine Live Sales Market Share by Region (2027–2032)
Table 21. Global Mumps Virus Vaccine Live Revenue by Region (US$ Million), 2021–2026
Table 22. Global Mumps Virus Vaccine Live Revenue Market Share by Region (2021–2026)
Table 23. Global Mumps Virus Vaccine Live Revenue by Region (US$ Million), 2027–2032
Table 24. Global Mumps Virus Vaccine Live Revenue Market Share by Region (2027–2032)
Table 25. North America Mumps Virus Vaccine Live Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Mumps Virus Vaccine Live Sales by Country (KG), 2021–2026
Table 27. North America Mumps Virus Vaccine Live Sales by Country (KG), 2027–2032
Table 28. North America Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2021–2026
Table 29. North America Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Mumps Virus Vaccine Live Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Mumps Virus Vaccine Live Sales by Country (KG), 2021–2026
Table 32. Europe Mumps Virus Vaccine Live Sales by Country (KG), 2027–2032
Table 33. Europe Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Mumps Virus Vaccine Live Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Mumps Virus Vaccine Live Sales by Region (KG), 2021–2026
Table 37. Asia Pacific Mumps Virus Vaccine Live Sales by Region (KG), 2027–2032
Table 38. Asia Pacific Mumps Virus Vaccine Live Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Mumps Virus Vaccine Live Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Mumps Virus Vaccine Live Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Mumps Virus Vaccine Live Sales by Country (KG), 2021–2026
Table 42. Latin America Mumps Virus Vaccine Live Sales by Country (KG), 2027–2032
Table 43. Latin America Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Mumps Virus Vaccine Live Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Mumps Virus Vaccine Live Sales by Country (KG), 2021–2026
Table 47. Middle East and Africa Mumps Virus Vaccine Live Sales by Country (KG), 2027–2032
Table 48. Middle East and Africa Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2027–2032
Table 50. Global Mumps Virus Vaccine Live Sales (KG) by Type (2021–2026)
Table 51. Global Mumps Virus Vaccine Live Sales (KG) by Type (2027–2032)
Table 52. Global Mumps Virus Vaccine Live Sales Market Share by Type (2021–2026)
Table 53. Global Mumps Virus Vaccine Live Sales Market Share by Type (2027–2032)
Table 54. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Mumps Virus Vaccine Live Revenue Market Share by Type (2021–2026)
Table 57. Global Mumps Virus Vaccine Live Revenue Market Share by Type (2027–2032)
Table 58. Global Mumps Virus Vaccine Live Price (US$/G) by Type (2021–2026)
Table 59. Global Mumps Virus Vaccine Live Price (US$/G) by Type (2027–2032)
Table 60. Global Mumps Virus Vaccine Live Sales (KG) by Application (2021–2026)
Table 61. Global Mumps Virus Vaccine Live Sales (KG) by Application (2027–2032)
Table 62. Global Mumps Virus Vaccine Live Sales Market Share by Application (2021–2026)
Table 63. Global Mumps Virus Vaccine Live Sales Market Share by Application (2027–2032)
Table 64. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Mumps Virus Vaccine Live Revenue Market Share by Application (2021–2026)
Table 67. Global Mumps Virus Vaccine Live Revenue Market Share by Application (2027–2032)
Table 68. Global Mumps Virus Vaccine Live Price (US$/G) by Application (2021–2026)
Table 69. Global Mumps Virus Vaccine Live Price (US$/G) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 73. Merck Mumps Virus Vaccine Live Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 78. GSK Mumps Virus Vaccine Live Product
Table 79. GSK Recent Developments/Updates
Table 80. SINOVAC Company Information
Table 81. SINOVAC Description and Business Overview
Table 82. SINOVAC Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 83. SINOVAC Mumps Virus Vaccine Live Product
Table 84. SINOVAC Recent Developments/Updates
Table 85. AIM Vaccine Company Information
Table 86. AIM Vaccine Description and Business Overview
Table 87. AIM Vaccine Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 88. AIM Vaccine Mumps Virus Vaccine Live Product
Table 89. AIM Vaccine Recent Developments/Updates
Table 90. Shanghai Institute of Biological Products Company Information
Table 91. Shanghai Institute of Biological Products Description and Business Overview
Table 92. Shanghai Institute of Biological Products Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 93. Shanghai Institute of Biological Products Mumps Virus Vaccine Live Product
Table 94. Shanghai Institute of Biological Products Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Mumps Virus Vaccine Live Distributors List
Table 98. Mumps Virus Vaccine Live Customers List
Table 99. Mumps Virus Vaccine Live Market Trends
Table 100. Mumps Virus Vaccine Live Market Drivers
Table 101. Mumps Virus Vaccine Live Market Challenges
Table 102. Mumps Virus Vaccine Live Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mumps Virus Vaccine Live
Figure 2. Global Mumps Virus Vaccine Live Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Mumps Virus Vaccine Live Market Share by Type: 2025 & 2032
Figure 4. Single-dose Medication Product Picture
Figure 5. Combination Medication Product Picture
Figure 6. Global Mumps Virus Vaccine Live Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Mumps Virus Vaccine Live Market Share by Application: 2025 & 2032
Figure 8. Children
Figure 9. Adults
Figure 10. Global Mumps Virus Vaccine Live Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Mumps Virus Vaccine Live Market Size (US$ Million), 2021–2032
Figure 12. Global Mumps Virus Vaccine Live Sales (KG), 2021–2032
Figure 13. Global Mumps Virus Vaccine Live Average Price (US$/G), 2021–2032
Figure 14. Mumps Virus Vaccine Live Report Years Considered
Figure 15. Mumps Virus Vaccine Live Sales Share by Manufacturers in 2025
Figure 16. Global Mumps Virus Vaccine Live Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Mumps Virus Vaccine Live Players: Market Share by Revenue in Mumps Virus Vaccine Live in 2025
Figure 18. Mumps Virus Vaccine Live Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Mumps Virus Vaccine Live Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Mumps Virus Vaccine Live Sales Market Share by Country (2021–2032)
Figure 21. North America Mumps Virus Vaccine Live Revenue Market Share by Country (2021–2032)
Figure 22. United States Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Mumps Virus Vaccine Live Sales Market Share by Country (2021–2032)
Figure 25. Europe Mumps Virus Vaccine Live Revenue Market Share by Country (2021–2032)
Figure 26. Germany Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Mumps Virus Vaccine Live Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Mumps Virus Vaccine Live Revenue Market Share by Region (2021–2032)
Figure 33. China Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Mumps Virus Vaccine Live Sales Market Share by Country (2021–2032)
Figure 41. Latin America Mumps Virus Vaccine Live Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Mumps Virus Vaccine Live Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Mumps Virus Vaccine Live Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Mumps Virus Vaccine Live by Type (2021–2032)
Figure 52. Global Revenue Market Share of Mumps Virus Vaccine Live by Type (2021–2032)
Figure 53. Global Mumps Virus Vaccine Live Price (US$/G) by Type (2021–2032)
Figure 54. Global Sales Market Share of Mumps Virus Vaccine Live by Application (2021–2032)
Figure 55. Global Revenue Market Share of Mumps Virus Vaccine Live by Application (2021–2032)
Figure 56. Global Mumps Virus Vaccine Live Price (US$/G) by Application (2021–2032)
Figure 57. Mumps Virus Vaccine Live Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Mumps Virus Vaccine Live Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Mumps Virus Vaccine Live Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Mumps Virus Vaccine Live Market Competitive Situation by Manufacturers in 2025
Table 4. Global Mumps Virus Vaccine Live Sales (KG) of Key Manufacturers (2021–2026)
Table 5. Global Mumps Virus Vaccine Live Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Mumps Virus Vaccine Live Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Mumps Virus Vaccine Live Average Price (US$/G) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Mumps Virus Vaccine Live, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Mumps Virus Vaccine Live, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Mumps Virus Vaccine Live, Product Types and Applications
Table 12. Global Key Manufacturers of Mumps Virus Vaccine Live, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mumps Virus Vaccine Live Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mumps Virus Vaccine Live Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mumps Virus Vaccine Live Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Mumps Virus Vaccine Live Sales by Region (KG), 2021–2026
Table 18. Global Mumps Virus Vaccine Live Sales Market Share by Region (2021–2026)
Table 19. Global Mumps Virus Vaccine Live Sales by Region (KG), 2027–2032
Table 20. Global Mumps Virus Vaccine Live Sales Market Share by Region (2027–2032)
Table 21. Global Mumps Virus Vaccine Live Revenue by Region (US$ Million), 2021–2026
Table 22. Global Mumps Virus Vaccine Live Revenue Market Share by Region (2021–2026)
Table 23. Global Mumps Virus Vaccine Live Revenue by Region (US$ Million), 2027–2032
Table 24. Global Mumps Virus Vaccine Live Revenue Market Share by Region (2027–2032)
Table 25. North America Mumps Virus Vaccine Live Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Mumps Virus Vaccine Live Sales by Country (KG), 2021–2026
Table 27. North America Mumps Virus Vaccine Live Sales by Country (KG), 2027–2032
Table 28. North America Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2021–2026
Table 29. North America Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Mumps Virus Vaccine Live Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Mumps Virus Vaccine Live Sales by Country (KG), 2021–2026
Table 32. Europe Mumps Virus Vaccine Live Sales by Country (KG), 2027–2032
Table 33. Europe Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Mumps Virus Vaccine Live Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Mumps Virus Vaccine Live Sales by Region (KG), 2021–2026
Table 37. Asia Pacific Mumps Virus Vaccine Live Sales by Region (KG), 2027–2032
Table 38. Asia Pacific Mumps Virus Vaccine Live Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Mumps Virus Vaccine Live Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Mumps Virus Vaccine Live Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Mumps Virus Vaccine Live Sales by Country (KG), 2021–2026
Table 42. Latin America Mumps Virus Vaccine Live Sales by Country (KG), 2027–2032
Table 43. Latin America Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Mumps Virus Vaccine Live Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Mumps Virus Vaccine Live Sales by Country (KG), 2021–2026
Table 47. Middle East and Africa Mumps Virus Vaccine Live Sales by Country (KG), 2027–2032
Table 48. Middle East and Africa Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2027–2032
Table 50. Global Mumps Virus Vaccine Live Sales (KG) by Type (2021–2026)
Table 51. Global Mumps Virus Vaccine Live Sales (KG) by Type (2027–2032)
Table 52. Global Mumps Virus Vaccine Live Sales Market Share by Type (2021–2026)
Table 53. Global Mumps Virus Vaccine Live Sales Market Share by Type (2027–2032)
Table 54. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Mumps Virus Vaccine Live Revenue Market Share by Type (2021–2026)
Table 57. Global Mumps Virus Vaccine Live Revenue Market Share by Type (2027–2032)
Table 58. Global Mumps Virus Vaccine Live Price (US$/G) by Type (2021–2026)
Table 59. Global Mumps Virus Vaccine Live Price (US$/G) by Type (2027–2032)
Table 60. Global Mumps Virus Vaccine Live Sales (KG) by Application (2021–2026)
Table 61. Global Mumps Virus Vaccine Live Sales (KG) by Application (2027–2032)
Table 62. Global Mumps Virus Vaccine Live Sales Market Share by Application (2021–2026)
Table 63. Global Mumps Virus Vaccine Live Sales Market Share by Application (2027–2032)
Table 64. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Mumps Virus Vaccine Live Revenue Market Share by Application (2021–2026)
Table 67. Global Mumps Virus Vaccine Live Revenue Market Share by Application (2027–2032)
Table 68. Global Mumps Virus Vaccine Live Price (US$/G) by Application (2021–2026)
Table 69. Global Mumps Virus Vaccine Live Price (US$/G) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 73. Merck Mumps Virus Vaccine Live Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 78. GSK Mumps Virus Vaccine Live Product
Table 79. GSK Recent Developments/Updates
Table 80. SINOVAC Company Information
Table 81. SINOVAC Description and Business Overview
Table 82. SINOVAC Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 83. SINOVAC Mumps Virus Vaccine Live Product
Table 84. SINOVAC Recent Developments/Updates
Table 85. AIM Vaccine Company Information
Table 86. AIM Vaccine Description and Business Overview
Table 87. AIM Vaccine Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 88. AIM Vaccine Mumps Virus Vaccine Live Product
Table 89. AIM Vaccine Recent Developments/Updates
Table 90. Shanghai Institute of Biological Products Company Information
Table 91. Shanghai Institute of Biological Products Description and Business Overview
Table 92. Shanghai Institute of Biological Products Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 93. Shanghai Institute of Biological Products Mumps Virus Vaccine Live Product
Table 94. Shanghai Institute of Biological Products Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Mumps Virus Vaccine Live Distributors List
Table 98. Mumps Virus Vaccine Live Customers List
Table 99. Mumps Virus Vaccine Live Market Trends
Table 100. Mumps Virus Vaccine Live Market Drivers
Table 101. Mumps Virus Vaccine Live Market Challenges
Table 102. Mumps Virus Vaccine Live Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mumps Virus Vaccine Live
Figure 2. Global Mumps Virus Vaccine Live Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Mumps Virus Vaccine Live Market Share by Type: 2025 & 2032
Figure 4. Single-dose Medication Product Picture
Figure 5. Combination Medication Product Picture
Figure 6. Global Mumps Virus Vaccine Live Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Mumps Virus Vaccine Live Market Share by Application: 2025 & 2032
Figure 8. Children
Figure 9. Adults
Figure 10. Global Mumps Virus Vaccine Live Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Mumps Virus Vaccine Live Market Size (US$ Million), 2021–2032
Figure 12. Global Mumps Virus Vaccine Live Sales (KG), 2021–2032
Figure 13. Global Mumps Virus Vaccine Live Average Price (US$/G), 2021–2032
Figure 14. Mumps Virus Vaccine Live Report Years Considered
Figure 15. Mumps Virus Vaccine Live Sales Share by Manufacturers in 2025
Figure 16. Global Mumps Virus Vaccine Live Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Mumps Virus Vaccine Live Players: Market Share by Revenue in Mumps Virus Vaccine Live in 2025
Figure 18. Mumps Virus Vaccine Live Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Mumps Virus Vaccine Live Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Mumps Virus Vaccine Live Sales Market Share by Country (2021–2032)
Figure 21. North America Mumps Virus Vaccine Live Revenue Market Share by Country (2021–2032)
Figure 22. United States Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Mumps Virus Vaccine Live Sales Market Share by Country (2021–2032)
Figure 25. Europe Mumps Virus Vaccine Live Revenue Market Share by Country (2021–2032)
Figure 26. Germany Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Mumps Virus Vaccine Live Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Mumps Virus Vaccine Live Revenue Market Share by Region (2021–2032)
Figure 33. China Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Mumps Virus Vaccine Live Sales Market Share by Country (2021–2032)
Figure 41. Latin America Mumps Virus Vaccine Live Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Mumps Virus Vaccine Live Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Mumps Virus Vaccine Live Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Mumps Virus Vaccine Live by Type (2021–2032)
Figure 52. Global Revenue Market Share of Mumps Virus Vaccine Live by Type (2021–2032)
Figure 53. Global Mumps Virus Vaccine Live Price (US$/G) by Type (2021–2032)
Figure 54. Global Sales Market Share of Mumps Virus Vaccine Live by Application (2021–2032)
Figure 55. Global Revenue Market Share of Mumps Virus Vaccine Live by Application (2021–2032)
Figure 56. Global Mumps Virus Vaccine Live Price (US$/G) by Application (2021–2032)
Figure 57. Mumps Virus Vaccine Live Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232